Investment firm’s connection to the Novo Nordisk Foundation provides a strong sense of purpose, report employees Award highlights collaborative, respectful workplace, and comprehensive employee benefits Boston, US, 23 May 2024 – Novo Holdings, a leading life science investor, today announced that its Boston office has been named a 2024 Best Place to Work by the Boston Business […]
Novo Holdings and A.P. Moller Holding have enabled a €150 million fundraise for CIRCTEC by leading with a €75 million equity investment. Financing includes €22.5 million of grants awarded by the Government of the Netherlands. The funding enables CIRCTEC to construct Europe’s largest end-of-life tyre pyrolysis recycling facility in Delfzijl, the Netherlands. The construction of […]
Novo Holdings A/S (“Novo Holdings”) today announced that it has agreed to acquire a majority stake in Single Use Support, a fast-growing life science tools company providing advanced technology solutions for the pharmaceutical production process. Novo Holdings will acquire an approximately 60% controlling stake, alongside the two company founders who will each retain 10% and […]
Financing led by Bioqube Ventures and Novo Holdings Commit is pioneering a novel approach to activating the complement component of the immune system to treat cancer and autoimmune diseases Its unique bispecific technology (BiCE™) engages the complement system, unleashing its power to selectively kill target cells Spin-out from Aarhus University in Denmark, a world leader […]
With Denmark as the centre of gravity, the ambition is to invest in, support and advance some of the world’s most promising quantum technology companies with applications in the life sciences. The quantum industry, which develops novel technologies such as quantum computers or quantum sensing based on quantum physics, holds the potential to dramatically impact […]
